Würzburg researchers at the Fraunhofer Translational Center for Regenerative Medicine therapies (TLZ-RT) together with the virologist Professor Jochen Bodem from the Julius Maximilians University (JMU) Würzburg investigate active ingredients against the SARS-CoV-2. For this purpose, they use special tissue models.

The coronavirus is currently having a firm grip on our society. Unfortunately, more medical research nowadays means more animal testing. But is there any other way? Many questions come up in this situation: What is behind Covid-19? How can we fight it? Why are animal experiments being carried out for this purpose and what successes have already been achieved by methods free of animal suffering? We would like to discuss these and other questions for you in the following overview.

In response to the corona crisis, the Johns Hopkins Center for Alternatives to Animal Testing (CAAT) has rededicated part of its in vitro toxicology funding program from Alan and Helene Goldberg to support the discovery of mechanisms, drugs or vaccines against Covid-19 and coronavirus to finance the project.

A German team of researchers has been investigating the mechanisms of the coronavirus. It has found a cellular protein that might be a potential target for the development of a treatment against the virus invasion into the lung cells.